American Century Companies
ACET icon

American Century Companies’s Adicet Bio ACET Stock Holding History

American Century Companies’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,755
Closed -$92.1K – 2880
2024
Q2 		$92.1K Buy
4,755
+887
+23% +$23.8K ﹤0.01% 2828
2024
Q1 		$145K Buy
+3,868
New +$160K ﹤0.01% 2814
2023
Q4 		– Sell
-1,362
Closed -$29.9K – 2877
2023
Q3 		$29.9K Buy
1,362
+303
+29% +$10.7K ﹤0.01% 2828
2023
Q2 		$41.2K Buy
1,059
+420
+66% +$37.1K ﹤0.01% 2773
2023
Q1 		$59.7K Buy
+639
New +$80.2K ﹤0.01% 2607

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

American Century Companies's ACET Position: Q3 2024 in Review

American Century Companies sold out of Adicet Bio (ACET) in Q3 2024, closing a stake of 4,755 shares — an estimated $92.1K sold.

American Century Companies first reported a position in ACET in Q1 2023 and held it in 5 quarters. The position peaked at $145K in Q1 2024. 64 funds tracked by Wall St. Rank hold ACET as of Q3 2024.

  • American Century Companies reported no remaining Adicet Bio position as of Q3 2024 after selling out during the quarter.
  • American Century Companies sold 4,755 Adicet Bio shares in Q3 2024, an estimated $92.1K.
  • American Century Companies first reported a position in Adicet Bio in Q1 2023 and held it in 5 quarters.
  • American Century Companies's Adicet Bio position peaked at $145K in Q1 2024.
  • 64 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2024.

Based on American Century Companies's 13F filing for Q3 2024, filed 12 Nov 2024.